Clinical Trials Logo

Clinical Trial Summary

This study aims to evaluate mitomycin C as an adjunct to endoscopic treatment of esophageal strictures.

This is a crossover, controlled, clinical trial in which children with esophageal stricture will be randomized in two groups to receive either topical mitomycin or no additional treatment during standard esophageal dilation session.


Clinical Trial Description

Topical mitomycin C has been used as an adjunct drug to endoscopic treatment of aero-digestive strictures. There has been some case reports and case series of this application in esophageal strictures in children, with good results. Nevertheless, it lacks a controlled clinical trial to access the efficacy of the mitomycin C in this context.

This study aims to evaluate mitomycin C as an adjunct to endoscopic treatment of esophageal strictures.

This is a crossover placebo-controlled single-blind clinical trial.

Patients: Subjects up to 18 year-old, with esophageal stricture requiring endoscopic dilation, either due to dysphagia or by stricture preventing passage of the endoscope.

Inclusion criteria:

- peptic esophageal stricture

- post-surgical esophageal stricture

- caustic esophageal stricture

The patient will be randomized by one treatment group, either A or B.

- A. during the first endoscopic procedure it will be applied of topical mitomycin C over the esophageal mucosa after dilation, then the second procedure (in two weeks) will be performed as a standard dilation, without mitomycin C.

- B. the first procedure will be performed in a standard way, and after two weeks, in the second procedure mytomicin-C will be spread over the esophageal mucosa.

The allocation will not be informed to the patient. At the end of the study protocol, the patients will be clinically evaluated and the dilation program will continue on discretion of the assistant doctor. The target esophageal bore is 11 mm (or 12.8 mm if age above 5 yrs).

Mitomycin C will be applied over the esophageal mucosa in the site of stricture after dilation with a cotton pledget soaked in solution (0.4mg/ml) by three minutes. The pledget will he held over the mucosa with a biopsy forceps.

Clinical evaluation. Dysphagia will be evaluated by a structured questionnaire, using a Likert scale. The patient will answer the questionnaire daily.

Main outcome measure: Number of days with improved symptom (dysphagia) after a session. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00551824
Study type Interventional
Source Federal University of São Paulo
Contact Rodrigo S Machado, PhD
Phone 55-11-5576-4344
Email rodrigo@gastroped.epm.br
Status Recruiting
Phase N/A
Start date October 2007
Completion date March 2009

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04372784 - Cryoablation for Benign Gastrointestinal Anastomotic Strictures N/A
Recruiting NCT05581173 - Self-Assembling Matrix Forming Gel to Prevent Stricture Formation
Terminated NCT04406428 - NKI Therapy Compared to Usual Care of Recurrent Esophagogastric Anastomotic Strictures N/A
Completed NCT04284826 - Mitomycin-C Injection Therapy in Refractory Esophageal Stricture N/A
Terminated NCT03898661 - Collagenase Clostridium Histolyticum for Refractory Iatrogenic Esophageal Strictures Early Phase 1
Withdrawn NCT04730076 - Balloon Dilation Methods for Benign Esophageal Stricture N/A
Active, not recruiting NCT03885310 - INGEST I Pilot Study N/A
Completed NCT02069847 - Prospective Evaluation of Budesonide for Prevention of Esophageal Strictures After Endotherapy Phase 2
Completed NCT03039608 - Effect of a Combination of Local Steroid Injection With Oral Steroid Administration for the Prevention on Esophageal Stricture After Endoscopic Submucosal Dissection for Early Esophageal Neoplasm N/A
Terminated NCT02354716 - EndoFLIP Use in Upper GI Tract Stenosis
Recruiting NCT05561114 - Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus Phase 3
Not yet recruiting NCT04524897 - The Use of Triamcinolone Injection in Treatment of Refractory Benign Esophageal Stricture in Children Phase 4
Not yet recruiting NCT04221867 - Feasibility and Therapeutic Potential of Free Fat Grafts in the Treatment of Esophageal Strictures (ESOGRAFT) N/A